Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Moss JG, Wu O, Bodenham AR, Agarwal R, et al. Lancet 2021;398:403-415.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moss JG, Wu O, Bodenham AR, Agarwal R, et al. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet 2021;398:403-415.
PMID: 34297997